Shrimanker, R., Pavord, I., Price, R., Bradford, E., Keene, O., & Yancey, S. (2018). Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma. American Thoracic Society.
Citace podle Chicago (17th ed.)Shrimanker, R., I. Pavord, R. Price, E. Bradford, O. Keene, a S. Yancey. Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma. American Thoracic Society, 2018.
Citace podle MLA (9th ed.)Shrimanker, R., et al. Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma. American Thoracic Society, 2018.